Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Geographic Atrophy GA Companies

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD), a progressive eye condition that can lead to vision loss. Geographic atrophy specifically involves the atrophy or degeneration of the central part of the retina known as the macula.

Geographic Atrophy Key Companies

Latest Geographic Atrophy Companies Update:

Second FDA Approval for GA Treatment: In August 2023, Iveric Bio received FDA approval for Izervay (avacincaptad pegol), the second ever-approved treatment for GA after Syfovre (pegcetacoplan injection). This offers increased options and hope for patients.

Focus on Novel Treatment Approaches: Companies like Apellis Pharmaceuticals and Gyroscope Therapeutics are researching and developing gene therapy and stem cell-based therapies for GA, potentially offering long-term solutions.

Clinical Trial Momentum: Several promising Phase 3 clinical trials are underway for potential GA treatments, including NGM Bio's NGM621 and Alkeus Pharmaceuticals' Gildeuretinol.

Diagnostic Advancements: New imaging technologies like swept-source Optical Coherence Tomography (OCT) are improving early detection and monitoring of GA progression, leading to timely treatment initiation.

List of Geographic Atrophy Key companies in the market

Apellis Pharmaceuticals, Inc. (US)

Iveric Bio (US)

Alkeus Pharmaceuticals, Inc. (US)

Hemera Biosciences LLC (US)

Allegro Ophthalmics, LLC (US)

Stealth BioTherapeutics (Cayman Islands)

Gyroscope Therapeutics Limited (UK)

F. Hoffmann-La Roche AG (Switzerland)

Genentech, Inc. (US)

Gensight Biologics SA (France)

Geographic Atrophy GA Market Highlights:

Geographic Atrophy GA Market Size

Geographic Atrophy GA Market Trends

Geographic Atrophy GA Market Analysis

Geographic Atrophy GA Market Share

Geographic Atrophy GA Market Highlights:

Geographic Atrophy GA Market Trends

Geographic Atrophy GA Market Analysis

Geographic Atrophy GA Market Share

Geographic Atrophy GA Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.